Quantum Biopharma (QNTM) Inventory (2019 - 2025)
Quantum Biopharma recorded quarterly Inventory of $52133.0 in Q4 2025, down 55.53% quarter-over-quarter from $117242.0 in Q4 2024, and down 55.53% year-over-year from $117242.0 in Q4 2024.
Quantum Biopharma's Inventory history runs 3 years deep, the most recent figure standing at $52133.0 for Q4 2025.
- In Q4 2025, Inventory fell 55.53% year-over-year to $52133.0; the TTM figure through Dec 2025 stood at $52133.0 (down 55.53% YoY), while the FY2025 annual figure was $52133.0, down 55.53% from the prior year.
- Inventory came in at $52133.0 for Q4 2025 at Quantum Biopharma, down from $117242.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $117242.0 in Q4 2024 to a low of $52133.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 52,133.00 |
| Dec 31, 2024 | 117,242.00 |
| Dec 31, 2019 | 714,274.74 |